Form 8-K - Current report:
SEC Accession No. 0001104659-21-059683
Filing Date
2021-05-03
Accepted
2021-05-03 07:30:14
Documents
14
Period of Report
2021-04-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2114846d1_8k.htm   iXBRL 8-K 30251
2 EXHIBIT 99.1 tm2114846d1_ex99-1.htm EX-99.1 12142
6 GRAPHIC tm2114846d1_ex99-1img01.jpg GRAPHIC 10962
  Complete submission text file 0001104659-21-059683.txt   238946

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA egrx-20210428.xsd EX-101.SCH 3184
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE egrx-20210428_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE egrx-20210428_pre.xml EX-101.PRE 22709
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2114846d1_8k_htm.xml XML 3619
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36306 | Film No.: 21881331
SIC: 2834 Pharmaceutical Preparations